| |
| |
|
| Insider
Information: |
Casamento Charles J |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
268,219 |
|
|
Indirect Shares
|
138,482 |
|
|
| Direct
Value |
$12,902 |
|
|
|
Indirect Value
|
$80,743 |
|
|
| Total
Shares |
406,701 |
|
|
| Total
Value |
$93,645 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
RespireRx Pharmaceuticals Inc |
RSPI |
Director |
2007-11-30 |
15,000 |
2005-02-08 |
0 |
Premium* |
|
|
Astex Pharmaceuticals Inc |
ASTX |
Director |
2013-05-03 |
0 |
2005-08-05 |
0 |
Premium* |
|
|
Osteologix, Inc. |
OLGXF |
Officer, Director |
2006-05-24 |
57,420 |
|
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-01-25 |
87,125 |
2011-12-06 |
0 |
Premium* |
|
|
International Stem Cell Corp |
ISCO |
Director |
2018-06-21 |
14,431 |
2012-05-29 |
0 |
Premium* |
|
|
Relmada Therapeutics, Inc. |
RLMD |
Director |
2022-04-01 |
0 |
2020-09-01 |
21,484 |
Premium* |
|
|
First Wave Biopharma Ord Shs |
FWBI |
Director |
2024-01-02 |
19,937 |
2020-03-19 |
116,998 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
Director |
2019-08-09 |
71,920 |
2018-11-15 |
0 |
Premium* |
|
|
Paxmedica, Inc. |
PXMD |
Director |
2024-03-12 |
2,386 |
2022-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ISCO |
International Stem Cell C... |
Director |
– • – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,403 |
10,103 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2016-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,104 |
12,207 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,042 |
16,249 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,391 |
20,640 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2016-10-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,334 |
21,974 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2016-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,523 |
29,497 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2017-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,642 |
34,139 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,415 |
45,681 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2017-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,175 |
50,856 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2018-01-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
34,000 |
16,856 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2018-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,527 |
22,383 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2018-05-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,280 |
10,103 |
0 |
- |
|
| ISCO |
International Stem Cell C... |
Director |
– • – |
2018-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,328 |
14,431 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
Director |
– • – |
2018-11-15 |
4 |
B |
$6.00 |
$30,000 |
D/D |
5,000 |
68,420 |
2.39 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
Director |
– • – |
2018-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,675 |
63,420 |
0 |
- |
|
| ETON |
Eton Pharmaceuticals, Inc... |
Director |
– • – |
2019-08-09 |
4 |
B |
$6.11 |
$21,370 |
D/D |
3,500 |
71,920 |
2.39 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-12-24 |
4 |
OE |
$3.24 |
$247,641 |
D/D |
67,578 |
67,578 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-12-24 |
4 |
D |
$40.64 |
$247,660 |
D/D |
(6,094) |
61,484 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-03-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
21,484 |
21,484 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-03-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
21,484 |
40,000 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-07-01 |
4 |
AS |
$43.89 |
$131,677 |
D/D |
(3,000) |
37,000 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-03 |
4 |
AS |
$35.74 |
$107,213 |
D/D |
(3,000) |
34,000 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
D |
$39.03 |
$85,437 |
D/D |
(2,189) |
58,173 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-08-18 |
4 |
OE |
$3.24 |
$85,413 |
D/D |
26,362 |
60,362 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2020-09-01 |
4 |
AS |
$34.74 |
$104,207 |
D/D |
(3,000) |
55,173 |
0 |
% |
|
101 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
